Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 32, 2019 - Issue 1
57
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Predictors and prognosis of no-reflow during primary percutaneous coronary intervention

, MD, DM, , MD, DM ORCID Icon, , MD, DM, , MD, DM, , MD, DM, , MD, DM, , MD, DM & , MD, DM show all
Pages 30-33 | Received 17 May 2018, Accepted 06 Aug 2018, Published online: 27 Dec 2018

  • Harrison RW, Aggarwal A, Ou FS, et al. Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction. Am J Cardiol. 2013;111(2):178–184. doi:10.1016/j.amjcard.2012.09.015.
  • Schwartz BG, Kloner RA. Coronary no reflow. J Mol Cell Cardiol. 2012;52(4):873–882. doi:10.1016/j.yjmcc.2011.06.009.
  • Reffelmann T, Hale SL, Li G, Kloner RA. Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion. Am J Physiol Heart Circ Physiol. 2002;282(2):H766–H772. doi:10.1152/ajpheart.00767.2001.
  • Ndrepepa G, Tiroch K, Keta D, et al. Predictive factors and impact of no-reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction. Circ Cardiovasc Intervent. 2010;3(1):27–33. doi:10.1161/CIRCINTERVENTIONS.109.896225.
  • Jaffe R, Dick A, Strauss BH. Prevention and treatment of microvascular obstruction related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach. JACC Cardiovasc Interv. 2010;3(7):695–704. doi:10.1016/j.jcin.2010.05.004.
  • Aung Naing K, Li L, Su Q, Wu T. Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction. Cochrane Database Syst Rev. 2013;6:CD009503.
  • Kelbaek H, Terkelsen CJ, Helqvist S, et al. Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial. J Am Coll Cardiol. 2008;51(9):899–905. doi:10.1016/j.jacc.2007.10.047.
  • Stone GW, Webb J, Cox DA, et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA. 2005;293(9):1063–1072. doi:10.1001/jama.293.9.1063.
  • Ndrepepa G, Tiroch K, Fusaro M, et al. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol. 2010;55(21):2383–2389. doi: 10.1016/j.jacc.2009.12.054.
  • Iwakura K, Ito H, Ikushima M, et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol. 2003;41(1):1–7.
  • Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000;355(9206):773–778. doi:10.1016/S0140-6736(99)08415-9.
  • Nagata Y, Usuda K, Uchiyama A, et al. Characteristics of the pathological images of coronary artery thrombi according to the infarct-related coronary artery in acute myocardial infarction. Circ J. 2004;68(4):308–314.
  • Cura FA, L’Allier PL, Kapadia SR, et al; GUSTO IIb and RAPPORT Investigators. Predictors and prognosis of suboptimal coronary blood flow after primary coronary angioplasty in patients with acute myocardial infarction. Am J Cardiol. 2001;88(2):124–128. doi:10.1016/S0002-9149(01)01605-8.
  • Mehta RH, Harjai KJ, Cox D, et al. Clinical and angiographic correlates and outcomes of suboptimal coronary flow inpatients with acute myocardial infarction undergoing primary percutaneous coronary intervention. J Am Coll Cardiol. 2003;42(10):1739–1746.
  • Parodi G, Valenti R, Carrabba N, et al. Long-term prognostic implications of nonoptimal primary angioplasty for acute myocardial infarction. Catheter Cardiovasc Interv. 2006;68(1):50–55. doi:10.1002/ccd.20729.
  • Sabin P, Koshy AG, Gupta PN, et al. Predictors of no-reflow during primary angioplasty for acute myocardial infarction, from Medical College Hospital, Trivandrum. Indian Heart. 2017;69(Suppl 1):S34–S45. doi: 10.1016/j.ihj.2016.12.012.
  • Zhou H, He XY, Zhuang SW, et al. Clinical and procedural predictors of no-reflow in patients with acute myocardial infarction after primary percutaneous coronary intervention. World J Emerg Med. 2014;5(2):96–102. doi:10.5847/wjem.j.issn.1920-8642.2014.02.003.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.